Full text loading...
- ISSN: 1570-1611
- E-ISSN: 1875-6212
-
Pleiotropic Effects of ARB in Diabetes Mellitus
- Source: Current Vascular Pharmacology, Volume 9, Issue 2, Mar 2011, p. 136 - 144
-
- 01 Mar 2011
Abstract
Evidence accumulated to date indicates that inhibition of the renin-angiotensin system with angiotensin receptor blockers (ARB) may prevent new-onset of diabetes. ARB is also used for the prevention of occurrence and progression of complications in diabetes and diabetic nephropathy. From the results of recent large-scale clinical studies, ARB is considered as a first choice drug in hypertensive patients with diabetes. In this review article, we focus on the effects of ARB on progression and prevention against diabetes as a metabolic-improving agent.
© Bentham Science Publishers